Tech Company Financing Transactions
Cytomos Funding Round
Cytomos, based in Edinburgh, Scotland, secured $6.3 million from Archangels, British Business Bank and Old College Capital.
Transaction Overview
Company Name
Announced On
11/19/2024
Transaction Type
Venture Equity
Amount
$6,300,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to drive sales of its first commercial product, Celledonia�, built on its cell-analysis technology platform AuraCyt, which is already generating significant market traction.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
13 Melville Street
Edinburgh, Scotland, EH3 7PE
UK
Edinburgh, Scotland, EH3 7PE
UK
Phone
Undisclosed
Website
Email Address
Overview
Cytomos Dielectric Spectroscopy (CDS�) connects your bioprocessing dots to make sense of the unseen and complete your biotechnology vision. This unique, full-stack, single-cell resolution analysis platform delivers label-free analytics that will revolutionise therapy, discovery and development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Alan Raymond
Chief Executive Officer
David Rigterink
Chief Financial Officer
Mark Collingbourne
Chief Scientific Officer
Lindsay Fraser
Chief Technical Officer
Gordon Sharp
Browse more venture capital transactions:
Prev: 11/19/2024: Firsty venture capital transaction
Next: 11/19/2024: Distyl AI venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on funding rounds that are announced publicly. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs